PLAY PODCASTS
Expert Insight on New Evidence Poised to Change the Treatment Landscape in Melanoma
Episode 85

Expert Insight on New Evidence Poised to Change the Treatment Landscape in Melanoma

In this podcast episode, Jeffrey S. Weber, MD, PhD; Allison Betof Warner, MD, PhD; and Hussein Tawbi, MD, PhD, discuss the key data on adjuvant and neoadjuvant therapy and review current and emerging treatment options for metastatic disease.

Decera Clinical Education Oncology Podcast · Hussein Tawbi MD PhD, Jeffrey S Weber MD PhD, Allison Betof Warner MD PhD

September 28, 202136m 31s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this podcast episode, Jeffrey S. Weber, MD, PhD; Allison Betof Warner, MD, PhD; and Hussein Tawbi, MD, PhD, discuss recent key data on adjuvant and neoadjuvant therapy and review the latest evidence on therapies for metastatic disease.

Link to full program:
https://bit.ly/3ogPjMo

Follow along with the downloadable slideset:
https://bit.ly/2XYNIzt

Presenters:  

Jeffrey S. Weber, MD, PhD
Deputy Director
Laura and Isaac Perlmutter Cancer Center
NYU Langone Health
Professor of Medicine
NYU Grossman School of Medicine
New York, New York

Allison Betof Warner, MD, PhD
Assistant Member
Assistant Attending Physician
Melanoma Service
Division of Solid Tumor Oncology
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York

Hussein Tawbi, MD, PhD
Professor
Department of Melanoma Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, Texas

 


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

relatlimabstage iiiblag-3encorafenibcheckmate 067checkmate 204nivolumabadjuvantpembrolizumabpembrolizumabbrafimspire 150lifileuceltrametinibabc studycobimetinibbinimetinibmelanomastarboardnrasipilimumabvemurafenibrelativity-047dabrafenibimmunotherapyneoadjuvantatezolizumabstage iiiacombi-i